Specialists of the Yeolyan Center at the 6th Armenian Oncology Congress

At the congress titled “Armenian Oncology: From Ambitious Plans to Their Implementation”, Yeolyan Hematology and Oncology Center was represented by presentations highlighting the Center’s achievements in pediatric oncology, malignant hematological diseases, and bone marrow transplantation. Notably, the Yeolyan Center is the only institution in Armenia providing comprehensive services across all three of these areas.

Presentations delivered by Yeolyan Center specialists:

Mery Petrosyan presented on “Primary Immunodeficiencies and Their Association with Oncological Diseases”, addressing the interconnection between immune system disorders and cancer development.

Mane Gizhlaryan discussed the use of post-transplant cyclophosphamide as a cost-effective strategy to expand access to pediatric hematopoietic stem cell transplantation in low- and middle-income countries. Her presentation emphasized the importance of localizing advanced treatment approaches.

Ruzanna Papyan presented the history of pediatric oncology development in Armenia, covering key stages of the field’s evolution, international collaborations, and the role of foundations, including City of Smile Charitable Foundation. She also shared treatment outcomes, which are notable for the country and reflect continuous progress in the field.

Gevorg Saghumyan focused on indolent B-cell lymphomas, outlining differential diagnostic approaches, current treatment standards, and emerging therapeutic options.

Karen Meliksetyan addressed the development of bone marrow transplantation services in Armenia, highlighting their strategic importance not only for the country but also for the region. He presented current capacities and future development directions.

Nerses Ghahramanyan spoke about the implementation of allogeneic bone marrow transplantation services, presenting associated complications and achieved outcomes. The presentation included a complex clinical case where, despite multiple severe complications, the patient is currently in stable condition thanks to the team’s high level of professionalism and consistent care. He also discussed the regional landscape and clarified the differences between autologous and allogeneic transplantation.

Participation of Yeolyan Hematology and Oncology Center in the Congress once again confirmed that hematology and pediatric oncology in Armenia are advancing from ambitious plans to real, measurable outcomes, ensuring modern and accessible treatment opportunities for patients.